Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.20.1
Stockholders' Equity (Tables)
 12 Months Ended
Jan. 31, 2020
Equity [Abstract]  
Fair Value of Stock Options Granted

The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option pricing model to determine the fair value of stock options granted:

 

 

 

 

 

For the Fiscal Years Ended January 31,

 

 

 

 

 

2020

 

 

2019

 

Risk-free interest rate

 

 

 

 

1.8

%

 

 

2.4

%

Expected volatility

 

 

 

 

50.5

%

 

 

41.0

%

Expected dividend yield

 

 

 

 

0.0

%

 

 

0.0

%

Expected term (in years)

 

 

 

 

6.0

 

 

 

6.0

 

 
Stock Option Activity

Stock Option Activity

The following table summarizes our stock option activity:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

Shares

 

 

Price

 

 

Term

 

 

Value

 

Outstanding as of January 31, 2019

 

 

4,124,202

 

 

$

3.28

 

 

 

6.96

 

 

$

32,000

 

Granted

 

 

1,555,000

 

 

 

1.94

 

 

 

 

 

 

 

 

 

Exercised

 

 

(195,461

)

 

 

3.04

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(2,715,275

)

 

 

2.72

 

 

 

 

 

 

 

 

 

Outstanding as of January 31, 2020

 

 

2,768,466

 

 

$

2.14

 

 

 

8.03

 

 

$

6,430,232

 

Vested and expected to vest as of January 31, 2020

 

 

2,552,241

 

 

$

2.09

 

 

 

8.52

 

 

$

6,018,110

 

Options exercisable as of January 31, 2020

 

 

677,220

 

 

$

2.67

 

 

 

6.18

 

 

$

1,271,367

 

 
Summary of Stock Unit Activity

The following table summarizes our stock unit activity:

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

Grant-Date

 

 

 

Number of Shares

 

 

Fair Value

 

Unvested balance as of January 31, 2019

 

 

1,695,996

 

 

$

3.00

 

Granted

 

 

873,892

 

 

 

2.13

 

Vested

 

 

(608,200

)

 

 

3.96

 

Forfeited

 

 

(816,735

)

 

 

2.27

 

Unvested balance as of January 31, 2020

 

 

1,144,953

 

 

$

2.30

 

 
Summary of Stock Based Compensation Expense Recognized

We recognized stock-based compensation expense within the accompanying consolidated statements of operations and comprehensive loss as follows:

 

 

 

For the Fiscal Years

Ended January 31,

 

 

 

2020

 

 

2019

 

 

 

(Amounts in thousands)

 

Cost of revenue

 

$

4

 

 

$

—

 

Research and development

 

 

302

 

 

 

186

 

Sales and marketing

 

 

230

 

 

 

373

 

General and administrative

 

 

615

 

 

 

2,380

 

 

 

$

1,151

 

 

$

2,939